Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency

C. Cavicchi, S. Malvagia, G. la Marca, S. Gasperini, M. A. Donati, E. Zammarchi, R. Guerrini, A. Morrone, E. Pasquini

Research output: Contribution to journalArticle

Abstract

In an expanded newborn screening program for inborn errors of metabolism by LC-MS/MS in Tuscany, six newborns out of 169,000 showed decreased blood citrulline levels. In one of them, molecular analysis of the OTC gene identified the known p.Trp265Leu mutation, which is correlated with late-onset ornithine transcarbamylase deficiency (OTCD). Hypocitrullinemia is not a reliable marker for OTCD newborn screening, especially for late-onset forms that may exhibit normal citrulline levels. However, when hypocitrullinemia is detected in a newborn in whom intestinal dysfunction and prematurity have been excluded, OTCD should be investigated first because of the OTCD incidence (1:14,000) and the small size of the OTC gene coding sequence.

Original languageEnglish
Pages (from-to)1292-1295
Number of pages4
JournalJournal of Pharmaceutical and Biomedical Analysis
Volume49
Issue number5
DOIs
Publication statusPublished - Jul 12 2009

Fingerprint

Ornithine Carbamoyltransferase Deficiency Disease
Ornithine Carbamoyltransferase
Screening
Citrulline
Genes
Inborn Errors Metabolism
Metabolism
Blood
Mutation
Incidence

Keywords

  • Expanded newborn screening
  • Hypocitrullinemia
  • Molecular analysis
  • Ornithine transcarbamylase deficiency (OTCD)
  • OTC gene

ASJC Scopus subject areas

  • Analytical Chemistry
  • Drug Discovery
  • Pharmaceutical Science
  • Spectroscopy
  • Clinical Biochemistry

Cite this

Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency. / Cavicchi, C.; Malvagia, S.; la Marca, G.; Gasperini, S.; Donati, M. A.; Zammarchi, E.; Guerrini, R.; Morrone, A.; Pasquini, E.

In: Journal of Pharmaceutical and Biomedical Analysis, Vol. 49, No. 5, 12.07.2009, p. 1292-1295.

Research output: Contribution to journalArticle

Cavicchi, C. ; Malvagia, S. ; la Marca, G. ; Gasperini, S. ; Donati, M. A. ; Zammarchi, E. ; Guerrini, R. ; Morrone, A. ; Pasquini, E. / Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency. In: Journal of Pharmaceutical and Biomedical Analysis. 2009 ; Vol. 49, No. 5. pp. 1292-1295.
@article{a747f252c3d0471d8783046a00b3df0f,
title = "Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency",
abstract = "In an expanded newborn screening program for inborn errors of metabolism by LC-MS/MS in Tuscany, six newborns out of 169,000 showed decreased blood citrulline levels. In one of them, molecular analysis of the OTC gene identified the known p.Trp265Leu mutation, which is correlated with late-onset ornithine transcarbamylase deficiency (OTCD). Hypocitrullinemia is not a reliable marker for OTCD newborn screening, especially for late-onset forms that may exhibit normal citrulline levels. However, when hypocitrullinemia is detected in a newborn in whom intestinal dysfunction and prematurity have been excluded, OTCD should be investigated first because of the OTCD incidence (1:14,000) and the small size of the OTC gene coding sequence.",
keywords = "Expanded newborn screening, Hypocitrullinemia, Molecular analysis, Ornithine transcarbamylase deficiency (OTCD), OTC gene",
author = "C. Cavicchi and S. Malvagia and {la Marca}, G. and S. Gasperini and Donati, {M. A.} and E. Zammarchi and R. Guerrini and A. Morrone and E. Pasquini",
year = "2009",
month = "7",
day = "12",
doi = "10.1016/j.jpba.2009.03.001",
language = "English",
volume = "49",
pages = "1292--1295",
journal = "Journal of Pharmaceutical and Biomedical Analysis",
issn = "0731-7085",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Hypocitrullinemia in expanded newborn screening by LC-MS/MS is not a reliable marker for ornithine transcarbamylase deficiency

AU - Cavicchi, C.

AU - Malvagia, S.

AU - la Marca, G.

AU - Gasperini, S.

AU - Donati, M. A.

AU - Zammarchi, E.

AU - Guerrini, R.

AU - Morrone, A.

AU - Pasquini, E.

PY - 2009/7/12

Y1 - 2009/7/12

N2 - In an expanded newborn screening program for inborn errors of metabolism by LC-MS/MS in Tuscany, six newborns out of 169,000 showed decreased blood citrulline levels. In one of them, molecular analysis of the OTC gene identified the known p.Trp265Leu mutation, which is correlated with late-onset ornithine transcarbamylase deficiency (OTCD). Hypocitrullinemia is not a reliable marker for OTCD newborn screening, especially for late-onset forms that may exhibit normal citrulline levels. However, when hypocitrullinemia is detected in a newborn in whom intestinal dysfunction and prematurity have been excluded, OTCD should be investigated first because of the OTCD incidence (1:14,000) and the small size of the OTC gene coding sequence.

AB - In an expanded newborn screening program for inborn errors of metabolism by LC-MS/MS in Tuscany, six newborns out of 169,000 showed decreased blood citrulline levels. In one of them, molecular analysis of the OTC gene identified the known p.Trp265Leu mutation, which is correlated with late-onset ornithine transcarbamylase deficiency (OTCD). Hypocitrullinemia is not a reliable marker for OTCD newborn screening, especially for late-onset forms that may exhibit normal citrulline levels. However, when hypocitrullinemia is detected in a newborn in whom intestinal dysfunction and prematurity have been excluded, OTCD should be investigated first because of the OTCD incidence (1:14,000) and the small size of the OTC gene coding sequence.

KW - Expanded newborn screening

KW - Hypocitrullinemia

KW - Molecular analysis

KW - Ornithine transcarbamylase deficiency (OTCD)

KW - OTC gene

UR - http://www.scopus.com/inward/record.url?scp=67349262351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349262351&partnerID=8YFLogxK

U2 - 10.1016/j.jpba.2009.03.001

DO - 10.1016/j.jpba.2009.03.001

M3 - Article

C2 - 19359120

AN - SCOPUS:67349262351

VL - 49

SP - 1292

EP - 1295

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

SN - 0731-7085

IS - 5

ER -